0,850  0,005  Antineoplastic (breast cancer)
0,833  0,006  Antineoplastic (lung cancer)
0,804  0,007  Antineoplastic (colorectal cancer)
0,797  0,007  Antineoplastic (colon cancer)
0,797  0,017  Apoptosis agonist
0,770  0,015  Caspase 9 stimulant
0,743  0,004  Tubulin antagonist
0,660  0,009  Antineoplastic (cervical cancer)
0,656  0,005  Antimitotic
0,572  0,005  Antidiabetic symptomatic
0,578  0,021  Prostate cancer treatment
0,545  0,005  Antineoplastic (squamous cell carcinoma)
0,527  0,008  Antineoplastic (carcinoma)
0,514  0,008  P-glycoprotein inhibitor
0,525  0,023  Antihypercholesterolemic
0,493  0,011  RNA-directed DNA polymerase inhibitor
0,478  0,020  Antineoplastic (non-small cell lung cancer)
0,498  0,041  Antibacterial
0,478  0,024  Caspase 3 stimulant
0,529  0,076  Antiinflammatory
0,476  0,026  Hepatic disorders treatment
0,466  0,032  Antineoplastic (ovarian cancer)
0,451  0,031  Antineoplastic (melanoma)
0,447  0,028  Antineoplastic (pancreatic cancer)
0,425  0,011  Hepatoprotectant
0,432  0,023  Hypoxia-inducible factor 1 alpha inhibitor
0,471  0,068  Antineoplastic (solid tumors)
0,419  0,031  Cytostatic
0,441  0,055  Transcription factor NF kappa B inhibitor
0,431  0,055  Antileukemic
0,409  0,038  AR expression inhibitor
0,393  0,027  Calcium channel activator
0,381  0,023  Antineoplastic enhancer
0,383  0,035  NOS2 expression inhibitor
0,376  0,031  Antineoplastic (lymphoma)
0,374  0,034  Cardiovascular analeptic
0,372  0,034  Proliferative diseases treatment
0,376  0,039  Cytotoxic
0,362  0,028  Antineoplastic (endocrine cancer)
0,364  0,032  Sodium/bile acid cotransporter inhibitor
0,394  0,066  Immunosuppressant
0,371  0,052  ICAM1 expression inhibitor
0,397  0,079  TNF expression inhibitor
0,331  0,029  Antineoplastic (sarcoma)
0,379  0,078  Antiprotozoal
0,352  0,053  NOS3 expression inhibitor
0,332  0,034  Nitric oxide antagonist
0,338  0,044  Antipyretic
0,302  0,009  Antineoplastic antibiotic
0,311  0,040  Antiulcerative
0,291  0,025  Diabetic retinopathy treatment
0,284  0,020  Topoisomerase II inhibitor
0,330  0,074  Bone diseases treatment
0,308  0,054  Sensitization
0,312  0,059  Teratogen
0,331  0,085  CYP3A4 substrate
0,259  0,014  Age-related macular degeneration treatment
0,276  0,034  VCAM1 expression inhibitor
0,250  0,009  Microtubule formation inhibitor
0,246  0,005  Beta tubulin antagonist
0,249  0,013  Expectorant
0,247  0,017  Aldose reductase substrate
0,294  0,069  Antiosteoporotic
0,240  0,019  Antiprotozoal (Coccidial)
0,248  0,034  Lipocortins synthesis antagonist
0,276  0,065  Embryotoxic
0,293  0,083  Antifungal
0,294  0,085  Antineoplastic (brain cancer)
0,219  0,018  Arachidonic acid antagonist
0,242  0,044  Pneumotoxic
0,252  0,060  Antiparasitic
0,197  0,006  Alpha tubulin antagonist
0,264  0,080  UGT2B4 substrate
0,219  0,037  Contraceptive
0,256  0,079  UGT1A9 substrate
0,261  0,084  GST M1-1 substrate
0,200  0,026  DNA intercalator
0,248  0,075  Antineoplastic (glioma)
0,205  0,036  Heat shock protein 90 antagonist
0,186  0,017  Topoisomerase II alpha inhibitor
0,278  0,115  Antiprotozoal (Plasmodium)
0,219  0,058  Antihelmintic
0,166  0,009  Aldose reductase inhibitor
0,279  0,124  CYP2C9 substrate
0,204  0,050  Antineoplastic (gastric cancer)
0,196  0,042  Antineoplastic (bone cancer)
0,163  0,010  Estrogen agonist
0,196  0,043  Lipid peroxidase inhibitor
0,162  0,011  Acetylcholine release stimulant
0,211  0,064  Abortion inducer
0,168  0,023  Antineoplastic alkaloid
0,237  0,092  Antineoplastic (bladder cancer)
0,219  0,075  Antineoplastic (glioblastoma multiforme)
0,229  0,085  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,271  0,127  GST A substrate
0,194  0,053  Heat shock protein 90 alpha antagonist
0,206  0,067  UDP-glucuronosyltransferase substrate
0,174  0,037  Protein-tyrosine phosphatase 1B inhibitor
0,199  0,062  UGT2B7 substrate
0,261  0,125  Antineoplastic (small cell lung cancer)
0,151  0,016  Antiviral (Trachoma)
0,222  0,092  DNA synthesis inhibitor
0,168  0,039  Antieczematic
0,179  0,050  Interferon gamma antagonist
0,157  0,028  Mucolytic
0,156  0,029  Ca2+-transporting ATPase inhibitor
0,155  0,030  Antineoplastic (uterine cancer)
0,224  0,099  Antioxidant
0,178  0,058  UGT2B10 substrate
0,172  0,055  UGT2B15 substrate
0,141  0,027  DNA directed RNA polymerase inhibitor
0,263  0,150  Antipruritic, allergic
0,189  0,075  VEGF expression inhibitor
0,131  0,023  SULT1E1 substrate
0,132  0,025  UGT2B11 substrate
0,177  0,073  Antirickettsial
0,179  0,075  Mutagenic
0,223  0,119  Antineoplastic (multiple myeloma)
0,150  0,047  Alkylator
0,175  0,073  Chemopreventive
0,135  0,033  Estrogen antagonist
0,145  0,045  Growth stimulant
0,184  0,084  UGT1A1 substrate
0,126  0,026  Estrogen receptor beta antagonist
0,165  0,066  Protein-tyrosine phosphatase inhibitor
0,115  0,019  Aromatase inhibitor
0,121  0,027  Antibiotic
0,139  0,045  Topoisomerase I inhibitor
0,173  0,080  Antipruritic, non-allergic
0,122  0,032  Androgen antagonist
0,159  0,070  Melanin inhibitor
0,095  0,007  Lipocortins synthesis agonist
0,099  0,015  Androgen agonist
0,151  0,067  Protein kinase stimulant
0,146  0,062  Antifungal enhancer
0,227  0,144  Antineoplastic (osteosarcoma)
0,091  0,010  Estrogen receptor alpha agonist
0,120  0,039  Anabolic
0,199  0,121  Spasmolytic
0,188  0,110  Nitric-oxide synthase stimulant
0,184  0,109  UGT1A6 substrate
0,131  0,056  Cholesterol synthesis inhibitor
0,191  0,117  Antineoplastic (renal cancer)
0,194  0,120  DNA damaging
0,163  0,090  Carcinogenic
0,092  0,019  Postmenopausal disorders treatment
0,125  0,056  Antiviral (Influenza B)
0,155  0,087  Liver fibrosis treatment
0,122  0,054  Photosensitizer
0,102  0,035  Contraceptive male
0,180  0,113  Antiprotozoal (Leishmania)
0,123  0,057  Antifungal (Pneumocystis)
0,203  0,137  Lipoxygenase inhibitor
0,072  0,008  Glucocorticoid antagonist
0,197  0,135  CYP2C19 substrate
0,116  0,056  Choleretic
0,213  0,153  CTGF expression inhibitor
0,096  0,036  Glycine receptor antagonist
0,073  0,015  Estradiol 17 beta-dehydrogenase inhibitor
0,087  0,029  Antitreponemal
0,122  0,064  Retinopathy treatment
0,158  0,102  Amyloid beta aggregation inhibitor
0,071  0,016  Estrogen receptor beta agonist
0,142  0,086  UGT2B9 substrate
0,129  0,075  Amylase inhibitor
0,159  0,106  Antiarrhythmic
0,073  0,023  Protein 50S ribosomal subunit inhibitor
0,135  0,086  Genotoxic
0,088  0,049  Antiprotozoal activity enhancer
0,188  0,149  Chemoprotective
0,041  0,005  Glucocorticoid agonist
0,124  0,090  Antimutagenic
0,072  0,038  SULT2A1 substrate
0,173  0,141  Peptidyltransferase inhibitor
0,188  0,158  Tyrosine 3 hydroxylase inhibitor
0,101  0,076  Endometrios treatment
0,061  0,036  Ryanodine receptor antagonist
0,028  0,005  Thyroid hormone alpha antagonist
0,065  0,042  HIV-1 integrase (3'-Processing) inhibitor
0,030  0,009  Dopamine D1 agonist
0,065  0,044  Dopamine D1 antagonist
0,125  0,105  Thrombolytic
0,027  0,008  Corticosteroid-like
0,057  0,039  Postcoital contraceptive
0,024  0,008  Progesterone receptor B antagonist
0,072  0,058  Na+ K+ transporting ATPase inhibitor
0,056  0,042  Pregnane X receptor antagonist
0,050  0,037  Anesthetic inhalation
0,042  0,029  Hypogonadism treatment
0,073  0,061  Estrogen receptor alpha antagonist
0,107  0,095  Contraceptive female
0,035  0,023  Tubulin agonist
0,154  0,142  Antiamyloidogenic
0,168  0,158  Antihypotensive
0,172  0,163  Cardioprotectant
0,100  0,092  Antiseptic
0,026  0,024  RNA-directed RNA polymerase stimulant
0,062  0,060  Glutamate (mGluR6) antagonist
0,080  0,079  Paget's disease treatment

